147 related articles for article (PubMed ID: 10762557)
1. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.
Buddles MR; Donne RL; Richards A; Goodship J; Goodship TH
Am J Hum Genet; 2000 May; 66(5):1721-2. PubMed ID: 10762557
[No Abstract] [Full Text] [Related]
2. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.
Ying L; Katz Y; Schlesinger M; Carmi R; Shalev H; Haider N; Beck G; Sheffield VC; Landau D
Am J Hum Genet; 1999 Dec; 65(6):1538-46. PubMed ID: 10577907
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.
Caprioli J; Bettinaglio P; Zipfel PF; Amadei B; Daina E; Gamba S; Skerka C; Marziliano N; Remuzzi G; Noris M
J Am Soc Nephrol; 2001 Feb; 12(2):297-307. PubMed ID: 11158219
[TBL] [Abstract][Full Text] [Related]
4. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.
Richards A; Buddles MR; Donne RL; Kaplan BS; Kirk E; Venning MC; Tielemans CL; Goodship JA; Goodship TH
Am J Hum Genet; 2001 Feb; 68(2):485-90. PubMed ID: 11170896
[TBL] [Abstract][Full Text] [Related]
5. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
Zipfel PF; Edey M; Heinen S; Józsi M; Richter H; Misselwitz J; Hoppe B; Routledge D; Strain L; Hughes AE; Goodship JA; Licht C; Goodship TH; Skerka C
PLoS Genet; 2007 Mar; 3(3):e41. PubMed ID: 17367211
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic-uremic syndrome: hereditary forms and forms associated with hereditary diseases.
Niaudet P; Gagnadoux MF; Broyer M; Salomon R
Adv Nephrol Necker Hosp; 2000; 30():261-80. PubMed ID: 11068647
[No Abstract] [Full Text] [Related]
7. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome.
Sánchez-Corral P; Pérez-Caballero D; Huarte O; Simckes AM; Goicoechea E; López-Trascasa M; de Córdoba SR
Am J Hum Genet; 2002 Dec; 71(6):1285-95. PubMed ID: 12424708
[TBL] [Abstract][Full Text] [Related]
9. Complement factor H and the haemolytic uraemic syndrome.
Taylor CM
Lancet; 2001 Oct; 358(9289):1200-2. PubMed ID: 11675053
[No Abstract] [Full Text] [Related]
10. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
[TBL] [Abstract][Full Text] [Related]
11. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
Francis NJ; McNicholas B; Awan A; Waldron M; Reddan D; Sadlier D; Kavanagh D; Strain L; Marchbank KJ; Harris CL; Goodship TH
Blood; 2012 Jan; 119(2):591-601. PubMed ID: 22058112
[TBL] [Abstract][Full Text] [Related]
12. Genotype/phenotype correlations in complement factor H deficiency arising from uniparental isodisomy.
Wilson V; Darlay R; Wong W; Wood KM; McFarlane J; Schejbel L; Schmidt IM; Harris CL; Tellez J; Hunze EM; Marchbank K; Goodship JA; Goodship TH
Am J Kidney Dis; 2013 Nov; 62(5):978-83. PubMed ID: 23870792
[TBL] [Abstract][Full Text] [Related]
13. Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.
Licht C; Weyersberg A; Heinen S; Stapenhorst L; Devenge J; Beck B; Waldherr R; Kirschfink M; Zipfel PF; Hoppe B
Am J Kidney Dis; 2005 Feb; 45(2):415-21. PubMed ID: 15685522
[TBL] [Abstract][Full Text] [Related]
14. Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?
Zipfel PF
Trends Immunol; 2001 Jul; 22(7):345-8. PubMed ID: 11429311
[TBL] [Abstract][Full Text] [Related]
15. Hemolytic uremic syndrome due to homozygous factor H deficiency.
Sethi SK; Marie-Agnes DD; Thaker N; Hari P; Bagga A
Clin Exp Nephrol; 2009 Oct; 13(5):526-530. PubMed ID: 19568827
[TBL] [Abstract][Full Text] [Related]
16. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited.
Johnson SA; Williams JM; Hakobyan S; Richards A; Perkins SJ; Marchbank KJ; Goodship TH; Morgan BP; Taylor CM; Savage CO
Mol Immunol; 2010 Apr; 47(7-8):1585-91. PubMed ID: 20304497
[TBL] [Abstract][Full Text] [Related]
17. Complement factor H and hemolytic uremic syndrome.
Zipfel PF; Skerka C; Caprioli J; Manuelian T; Neumann HH; Noris M; Remuzzi G
Int Immunopharmacol; 2001 Mar; 1(3):461-8. PubMed ID: 11367530
[TBL] [Abstract][Full Text] [Related]
18. Complement dysregulation in haemolytic uraemic syndrome.
Bonnardeaux A; Pichette V
Lancet; 2003 Nov; 362(9395):1514-5. PubMed ID: 14615103
[No Abstract] [Full Text] [Related]
19. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
Józsi M; Heinen S; Hartmann A; Ostrowicz CW; Hälbich S; Richter H; Kunert A; Licht C; Saunders RE; Perkins SJ; Zipfel PF; Skerka C
J Am Soc Nephrol; 2006 Jan; 17(1):170-7. PubMed ID: 16338962
[TBL] [Abstract][Full Text] [Related]
20. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP
Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
